Toggle navigation
Home
Search
Services
Blog
Contact
About
Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053
Vaxgen Inc.
Search grants from Vaxgen Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
MiR-223 Regulation of Blood-Brain Barrier Function After Traumatic Brain Injury
Computational Neuroscience Annual Meeting
Inverted Spot Laser Scanning Confocal Microscope
Amelioration of Retinal Photic Injury
Capillary Transport by Endothelial Vesicles
Recently added grants:
Blrd Research Career Scientist Award Application
Strategic Molecular Activations for the Selective Synthesis of 2-Deoxy-Beta-Glycosides, and for the Synthesis of Novel Donor-Acceptor Stenhouse Adducts
A Dental implant registry of treatment outcomes of implant therapy by practitioners in the National Dental Practice Based Research Network
Technology-based intervention for alcohol-related sexual risk behaviors in young women with sexual victimization histories
Melanocortin 3 receptor in neural circuits linking reproductive state and metabolism
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI030053-007
Application #
7191311
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Vaxgen Inc.
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 AI
Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053
/ Vaxgen Inc.
NIH 2005
N01 AI
Production and Testing of Anthrax Recombinant Protective Antigen /Rpa/-266030053
/ Vaxgen Inc.
NIH 2004
N01 AI
Production and Testing of rPA Vaccine-26630053
/ Vaxgen Inc.
NIH 2003
N01 AI
Production and Testing of Anthrax Recombinant Protective Antigen Vacci-
/ Vaxgen Inc.
Publications
Omland, Kristian S; Brys, April; Lansky, David et al.
(2008)
Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species.
Clin Vaccine Immunol 15:946-53
Comments
Be the first to comment on this grant